Ramkumar et al. wanted to identify pathways that control the expression of B-cell maturation antigen (BCMA) since in one of the ways MM develops resistance against immunotherapy is via loss of surface antigen expression. Here, TNFRSF17 is linked to Miyoshi myopathy.